|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 16.34 USD | -3.26% |
|
+0.12% | +31.24% |
| 08-28 | Shield Therapeutics to Take Over US Commercialization of ACCRUFeR | MT |
| 08-27 | Shield Therapeutics takes full control of ferric maltol product in US | AN |
Chart: Technical Analysis
Stock exchange
Nasdaq
VTRS 16.34 $
-3.26%
102M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| VTRS | 16.34USD | -3.26% | 102M $ | |
CBOE
| VTRS | 16.34USD | -3.23% | 3.65M $ | |
Tradegate
| VIA | 14.11EUR | -2.66% | 27.48K € | |
Boerse Muenchen
| VIA | 14.14EUR | -2.64% | 6.15K € | |
Börse Stuttgart
| VIA | 14.06EUR | -3.05% | 4.47K € | |
Deutsche Boerse AG
| VIA | 14.45EUR | -0.30% | 1.18K € | |
Xetra
| VIA | 14.27EUR | -2.41% | 456.7 € | |
Mexican S.E.
| VTRS * | 276.02MXN | -6.43% | 6.9K $ | |
London S.E.
| 0A5V | 16.60USD | -2.64% | 149.4 $ | |
Borsa Italiana
| 1VTRS | 14.64EUR | +1.02% | 87.82 € | |
Wiener Boerse
| VTRS | 14.28EUR | -2.47% | 0 € | |
Swiss Exchange
| VTRS | 16.69USD | -1.51% | 0 $ | |
Swiss Exchange
| VTRS | 13.48CHF | -1.04% | 0 CHF | |
CBOE
| 0A5V | 11.71EUR | 0.00% | 0 € | |
CBOE
| 13.96EUR | 0.00% | 0 € |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 16.96 | 17.86 | 17.56 |
| Spread/Res. | -3.66% | -8.51% | -6.95% |
| Spread/Supp. | +1.87% | +6.31% | +25.21% |
| Support | 16.04 | 15.37 | 13.05 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- VTRS Stock
- Charts Viatris Inc.
Select your edition
All financial news and data tailored to specific country editions

















